Related Experiment Video

Updated: Jul 19, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

New evaluation therapies for sepsis

G Deby-Dupont1, P P Damas, M Lamy

  • 1Department of Anaesthesiology and Intensive Care, University Hospital, B 35, and Centre for Oxygen Research and Development (CORD), Institut de Chimie, B6a, Domaine Universitaire du Sart Tilman, 4000 Liège, Belgium.

Current Opinion in Anaesthesiology
|October 3, 2006
PubMed

Insights

Recent sepsis and septic shock treatments show disappointing results from antimediator therapies. Ongoing research explores new approaches and analyzes past clinical trial failures to improve patient outcomes.

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Pharmacology

Background:

  • Sepsis and septic shock remain leading causes of mortality worldwide.
  • Effective treatment strategies are urgently needed to improve patient survival rates.
  • Recent advances in understanding sepsis pathophysiology have spurred novel therapeutic development.

Purpose of the Study:

  • To review and analyze recent literature (last 2 years) on sepsis and septic shock treatment.
  • To evaluate the efficacy of various therapeutic approaches, particularly antimediator therapies.
  • To identify reasons for the limited success of past clinical trials in sepsis treatment.

Main Methods:

  • Comprehensive literature search of databases for studies published in the last two years.
  • Systematic review and critical analysis of clinical trial data, focusing on phase II and III studies.
  • Synthesis of findings regarding the effectiveness of different treatment modalities.

Main Results:

  • Most antimediator therapies evaluated in recent phase II/III clinical trials have shown disappointing outcomes.
  • Despite setbacks, numerous novel therapeutic strategies are under investigation or in development.
  • Published analyses highlight critical factors contributing to the failure of previous clinical trials.

Conclusions:

  • Current antimediator therapies for sepsis and septic shock have largely failed to demonstrate significant clinical benefit.
  • Future research must focus on innovative therapeutic targets and rigorous trial design.
  • Understanding the reasons behind past failures is crucial for advancing sepsis treatment.

More Related Videos

Cecal Ligation Puncture Procedure11:53

Cecal Ligation Puncture Procedure

Published on: May 7, 2011

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...